home \| contact \| pubmed search \| Keyword Search:

GAMMAGARD LIQUID GAMMAGARD S/D GAMMAGARD S/D IgA less than 1 µg/mL in a 5% solution Order Therapeutics Important Safety Information Prescribing Information

Sign Up Today The Immune Disease eNewsletter gives you the latest updates.

GAMMAGARD Therapies for Primary Immune Deficiency

GAMMAGARD S/D

[Immune Globulin Intravenous (Human)],
IgA less than 1 µg/mL in a 5% solution.

low iga Available January 2, 2008 for your patients who require a Low IgA IVIG therapy. Baxter offers GAMMAGARD S/D with IgA less than 1 µg/mL in a 5% solution.

GAMMAGARD S/D with IgA less than 1 µg/mL in a 5% solution must not be used in patients with selective IgA deficiency where the deficiency is the only abnormality of concern.

Available in both 5g and 10g sizes.
Unique product codes to simplify ordering.
IgA less than 1 µg/mL in a 5% solution.
No clinical studies have been specifically conducted using only lots whose IgA content was less than 1 µg/mL.
IVIG preparations depleted of IgA (0.4 to 2.9 µg/mL) were shown to be better tolerated by a limited number of patients who reacted to IVIG preparations with higher IgA concentrations. However, the concentration of IgA that will not provoke a reaction is not known, and therefore all IVIG preparations carry the risk of inducing an anaphylactic reaction to IgA.

Learn more about GAMMAGARD S/D with IgA less than 1 µg/mL in a 5% solution.

GAMMAGARD Liquid

[Immune Globulin Intravenous (Human)] 10%

GAMMAGARD LIQUID 10% is a specially formulated 10% IVIG solution with demonstrated efficacy, safety, tolerability, and convenience.

The FIRST 10% IVIG Solution with...

The unique combination of no added sugars, sodium, or preservatives, plus latex-free packaging.¹
A dedicated 3-step process specifically designed for viral inactivation/removal.¹
9-month room temperature (25°C [77°F]) storage within 24 months of the date of processing.¹
Best-in-class patient and professional support from Baxter.

Learn more about GAMMAGARD LIQUID

Updates

IVEEGAM EN
Starting in January 2007, IVEEGAM EN [Immune Globulin Intravenous (Human)] will no longer be available. Read Letter to Physicians for more information.
POLYGAM S/D
As of June 2006, Baxter will no longer produce POLYGAM S/D [Immune Globulin Intravenous (Human)]. Read Customer Letter with details.
Biological Distributors
View a list of Baxter’s Authorized
Biological Distributors.

GAMMAGARD S/D is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10%

Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD S/D [Immune Globulin Intravenous (Human)]

Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD S/D [Immune Globulin Intravenous (Human)], IgA less than 1 µg/mL in a 5% solution.

Please see the Important Safety Information and Full Prescribing Information for IVEEGAM EN [Immune Globulin Intravenous (Human)]

Please see the Important Safety Information and Full Prescribing Information for POLYGAM S/D [Immune Globulin Intravenous (Human)]

To view PDFs, you will need
Adobe® Acrobat® Reader® software.

1. GAMMAGARD LIQUID Immune Globulin Intravenous (Human) 10% [package insert].
Deerfield, IL. Baxter International Inc.; April 2005.

Sign Up Today

GAMMAGARD Therapies for Primary Immune Deficiency

GAMMAGARD S/D

GAMMAGARD Liquid

The FIRST 10% IVIG Solution with...

Updates